Belite Bio, IncBelite Bio, IncBelite Bio, Inc

Belite Bio, Inc

No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.38 USD per share, beating the −0.55 USD estimate by 30.43%. Revenue for the same period reached 0.00 USD, despite the estimate of 0.00 USD. For the next quarter, analysts expect −0.64 USD in earnings per share and 0.00 USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise